Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis

Journal of Crohn's and Colitis

Volumn 10, Issue 11, 2016, Pages 1324-1335

  Hernández Chirlaque, Cristina ^a   Aranda, Carlos J ^a   Ocón, Borja ^a   Capitán Cañadas, Fermín ^a   Ortega González, Mercedes ^a   Carrero, Juan Jesús ^b   Suárez, María Dolores ^a   Zarzuelo, Antonio ^a   de Medina, Fermín Sánchez ^a   Martínez Augustin, Olga ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Barrier function; Germ free; Microbiota; Mucosal

Indexed keywords

ALKALINE PHOSPHATASE; CLAUDIN 4; CYCLIN D1; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 27; INTERLEUKIN 6; MUCIN 3; MYELOPEROXIDASE; OCCLUDIN; TRANSCRIPTION FACTOR FOXP3; TREFOIL FACTOR 3; TUMOR NECROSIS FACTOR; ANTIINFECTIVE AGENT; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD VESSEL COMPLIANCE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME ACTIVITY; EXPERIMENTAL COLITIS; FEMALE; INTESTINE FLORA; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OCCULT BLOOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ISOLATION; SIGNAL TRANSDUCTION; SPLEEN CELL; WEIGHT REDUCTION; ANIMAL; CELL SURVIVAL; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; GERMFREE ANIMAL; INTESTINE MUCOSA; METABOLISM; PATHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL MICROBIOME; GERM-FREE LIFE; INTESTINAL MUCOSA; MALE; MICE;

EID: 85012298937     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw096     Document Type: Article

References (45)

1. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006;47:241-59.
2. Schirbel A, Fiocchi C. Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 2010;11:266-76.
3. Sánchez de Medina F, Romero-Calvo I, Mascaraque C, Martínez-Augustin O. Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis 2014;20:2394-404.
4. Gordon HA, Bruckner-Kardoss E, Wostmann BS. Aging in germ-free mice: Life tables and lesions observed at natural death. J Gerontol 1966;21:380-7.
5. Snyder DL, Pollard M, Wostmann BS, Luckert P. Life span, morphology, and pathology of diet-restricted germ-free and conventional lobund-wistar rats. J Gerontol 1990;45:B52-8.
6. Donowitz M, Binder HJ. Mechanism of fluid and electrolyte secretion in the germ-free rat cecum. Dig Dis Sci 1979;24:551-9.
7. Kitajima S, Morimoto M, Sagara E. A model for dextran sodium sulfate [DSS]-induced mouse colitis: Bacterial degradation of DSS does not occur after incubation with mouse cecal contents. Exp Anim 2002;51:203-6.
8. Kitajima S, Morimoto M, Sagara E, Shimizu C, Ikeda Y. Dextran sodium sulfate-induced colitis in germ-free IQI/JIC mice. Exp Anim 2001;50: 387-95.
9. Solomon L, Mansor S, Mallon P, et al. The dextran sulphate sodium [DSS] model of colitis: An overview. Comp Clin Pathol 2010;19:235-9.
10. Sydora BC, Albert EJ, Foshaug RR, et al. Intravenous injection of endogenous microbial components abrogates DSS-induced colitis. Dig Dis Sci 2012;57:345-54.
11. Kommedal Ø, Simmon K, Karaca D, Langeland N, Wiker HG. Dual priming oligonucleotides for broad-range amplification of the bacterial 16s rRNA gene directly from human clinical specimens. J Clin Microbiol 2012;50:1289-94.
12. Sanchez de Medina F, Martinez-Augustin O, Gonzalez R, et al. Induction of alkaline phosphatase in the inflamed intestine: A novel pharmacological target for inflammatory bowel disease. Biochem Pharmacol 2004;68:2317-26.
13. Bessey OA, Lowry OH, Brook MJ. Rapid colorimetric method for the determination of alkaline phosphatase in five cubic mililiters of serum. J Biol Chem 1946;164:321-9.
14. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
15. Welch CL, Young DS. Spectrophotometry of occult blood in faeces. Clin Chem 1983;29:2022-5.
16. Niess JH, Leithauser F, Adler G, Reimann J. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol 2008;180:559-68.
17. Bamias G, Okazawa A, Rivera-Nieves J, et al. Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis. J Immunol 2007;178:1809-18.
18. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: Lessons from mouse infection models. Nat Rev Microbiol 2010;8:564-77.
19. Garcia-Lafuente A, Antolin M, Guarner F, et al. Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 1997;272:G10-5.
20. Onderdonk AB, Franklin ML, Cisneros RL. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun 1981;32:225-31.
21. Seksik P, Sokol H, Lepage P, et al. Review article: The role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006;24[Suppl 3]:11-8.
22. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33.
23. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94.
24. Bylund-Fellenius AC, Landström E, Axelsson LG, Midtvedt T. Experimental colitis induced by dextran sulphate in normal and germfree mice. Microb Ecol Health Dis 1994;7:207-15.
25. Hudcovic T, Stepankova R, Cebra J, Tlaskalova-Hogenova H. The role of microflora in the development of intestinal inflammation: Acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol [Praha] 2001;46:565-72.
26. Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 2001;69:2277-85.
27. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor gpr43. Nature 2009;461:1282-6.
28. Pils MC, Bleich A, Prinz I, et al. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10. Inflamm Bowel Dis 2011;17:2038-46.
29. Ricketts CR. Dextran sulphate a synthetic analogue of heparin. Biochem J 1952;51:129-33.
30. McLeod AD, Friend DR, Tozer TN. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: Hydrolysis in rat gastrointestinal tract contents. J Pharm Sci 1994;83:1284-8.
31. Kitajima S, Takuma S, Morimoto M. Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. Exp Anim 2000;49:9-15.
32. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat Rev Immunol 2010;10:131-44.
33. Pearson JP, Brownlee IA. The interaction of large bowel microflora with the colonic mucus barrier. Int J Inflamm 2010;2010:321426.
34. Neurath MF. New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol 2014;7:6-19.
35. Martinez-Augustin O, Romero-Calvo I, Suarez MD, Zarzuelo A, Sanchez de Medina F. Molecular bases of impaired water and ion movements in inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:114-27.
36. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013;504:451-5.
37. Boirivant M, Amendola A, Butera A, et al. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis. Gastroenterology 2008;135:1612-23 e5.
38. Youakim A, Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 1999;276:G1279-88.
39. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 2008;130:55-70.
40. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
41. Marks BR, Nowyhed HN, Choi J-Y, et al. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol 2009;10:1125-32.
42. Massot B, Michel M-L, Diem S, et al. TLR-induced cytokines promote effective proinflammatory natural th17 cell responses. J Immunol 2014;192:5635-42.
43. Liu B, Tonkonogy SL, Sartor RB. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology 2011;141:653-62, 62.
44. Busman-Sahay KO, Walrath T, Huber S, O'Connor W Jr. Cytokine crowdsourcing: Multicellular production of th17-associated cytokines. J Leukoc Biol 2015;97:499-510.
45. Diegelmann J, Olszak T, Göke B, Blumberg RS, Brand S. A novel role for interleukin-27 [IL-27] as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription [stat] protein signaling and induction of antibacterial and anti-inflammatory proteins. J Biol Chem 2012;287:286-98.